|
시장보고서
상품코드
980359
중국의 피부진균증 치료제 시장Anti Dermatomycosis Skin Drugs Markets in China |
||||||
중국의 피부진균증 치료제 수요는 지난 10년간 급증했습니다. 향후 10년간도 생산과 수요 양쪽 모두 증가세를 지속할 전망입니다. 중국의 경제는 20년 이상에 걸쳐 광공업 생산, 수출입, 소비자 소비, 설비 투자의 지속적 증가에 의해 자극되어 온 상당히 빠른 성장을 유지하고 있습니다.
중국의 피부진균증 치료제(Anti Dermatomycosis Skin Drugs) 시장에 대해 조사했으며, 중국의 경제 동향, 투자 환경, 업계 발전, 수요와 공급, 업계 생산능력, 업계 구조, 마케팅 채널, 주요 시장 진출기업 분석, 과거 데이터와 향후 예측 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
- 조사 범위와 조사 방법
- 개요
제2장 사업 환경
- 경제 전망
- 주요 경제지표
- 산업 생산
- 인구와 노동력
- 외국 투자
- 외국 무역
- 금융/세법
- 은행 시스템과 규제
- 외환
- 세금/관세율/관세
제3장 피부진균증 치료제 업계 평가
- 피부진균증 치료제 업계 개요
- 시장 규모
- 시장 성장 촉진요인
- 판매
- 주요 생산업체의 생산거점/판매
- 주요 생산업체의 시장 점유율
- 인건비
- 잠재적 시장 진출기업
- 주요 외국 투자
- 기술 개발
제4장 피부진균증 치료제 생산·수요
- 개요
- 피부진균증 치료제 수요 : 지역별
- 피부진균증 치료제 판매
- Fluconazole
- Itraconazole
- Terbinafine
- Econazole
- Miconazole Nitrate
- Amphotericin B
- Ketoconazole
- Clotrimazole
- Caspofungin
- 기타 피부진균증 치료제 매출 및 시장 점유율
- 피부진균증 치료제 수출입
- 가격 동향
제5장 피부진균증 치료제 시장 전망
- 피부진균증 치료제 시장 전망 : 개요
- 구체적인 정부 규제
- 소비자 지출 동향
- 북동부
- 북부
- 남동부
- 중앙부
- 남서부
- 북서부
- 인구통계 동향
- 헬스케어 업계 동향
- 병원과 병상
제6장 시장 진출 채널
- 중국 시장 진출 개요
- 중국의 유통 시스템
- 소화성 궤양 약물 유통경로
- 운송 및 화물 인프라
- 통신
- 중국 시장 진출
- 대중국 수출
- 간접 수출
- 직접 수출
- 라이선스와 위탁 제조
- 중국에서의 조립
- 수탁제조
- 무역 허가
- 투자
- 에퀴티(equity) 조인트 벤처
- 계약에 의한 조인트 벤처
- 완전 외자 기업
제7장 생산업체 디렉토리
- 생산업체 개요
China's demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.
Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.
TABLE OF CONTENTS
I. INTRODUCTION
- Report Scope and Methodology
- Executive Summary
II. BUSINESS ENVIRONMENT
- Economic Outlook
- Key Economic Indicators
- Industrial Output
- Population and Labor
- Foreign Investment
- Foreign Trade
- Financial and Tax Regulations
- Banking System and Regulations
- Foreign Exchange
- Taxes, Tariff and Custom Duties
III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS
- Anti Dermatomycosis Skin Drugs Industry Structure
- Market Size
- Market Growth Driver
- Anti Dermatomycosis Skin Drugs Sales Volume
- Major Producer Facility Locations and Sales Volume
- Market Share of Key Producers
- Labor Cost
- Potential Entrants
- Major Distributors
- Major Foreign Investments
- Technology Development
IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND
- Overview
- Demand of Anti Dermatomycosis Skin Drugs by Region
- Anti Dermatomycosis Skin Drugs Sales Volume
- Fluconazole Sales Volume and Market Share
- Itraconazole Sales Volume and Market Share
- Terbinafine Sales Volume and Market Share
- Econazole Sales Volume and Market Share
- Miconazole Nitrate Sales Volume and Market Share
- Amphotericin B Sales Volume and Market Share
- Ketoconazole Sales Volume and Market Share
- Clotrimazole Sales Volume and Market Share
- Caspofungin Sales Volume and Market Share
- Other Anti Dermato Mycosis Skin Drugs Sales Volume and Market Share
- Anti Dermatomycosis Skin Drugs Imports and Exports
- Pricing Trends
V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK
- Anti Dermatomycosis Skin Drugs Markets Outlook Overview Concrete Government Regulations
- Health Care Insurance Industry Overview
- Consumer Spending Trends
- Northeast
- North
- Southeast
- Central
- Southwest
- Northwest
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
VI. MARKET ENTRY CHANNELS
- China Market Entry Overview
- China's Distribution System
- Anti Peptic Ulcer Drugs Distribution Channels
- Transportation and Freight Infrastructure
- Communications
- China's Market Entry
- Export to China
- Indirect Export
- Direct Export
- License and Contract Manufacture
- Assembling in China
- Contract Manufacturing
- Trade Permit
- Investment
- Equity Joint Venture
- Contractual Joint Venture
- Wholly Foreign-Owned Enterprise
VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY
- Anti Dermatomycosis Skin Drugs Producer Profiles and Directory
